BioSight
Companies
ACHIEVE LIFE SCIENCES, INC. logo

ACHV

NASDAQSEATTLE, WA
ACHIEVE LIFE SCIENCES, INC.

Achieve Life Sciences is a clinical-stage biopharmaceutical company developing cytisinicline, a small molecule for smoking cessation and nicotine dependence treatment. The company is advancing cytisinicline through clinical trials with plans to expand its development across multiple methods of nicotine dependence delivery beyond the initial smoking cessation indication.

Price history not yet available for ACHV.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar